ArticleFrontiers in oncology2021

Erratum: The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.